A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the drug motexafin gadolinium will be an
effective treatment for patients who have chronic lymphocytic leukemia (CLL) that has come
back after treatment or that has stopped responding to treatment.